Latest Leadership News

Resimac Group Ltd delivered a 42% jump in statutory profit for FY26 despite flat revenue, driven by strong home loan growth and improved margins, while raising its final dividend to 6 cents per share.

Minrex Resources has reported strong assay results from the first ten infill drill holes at its Barje deposit, revealing shallow, high-grade gold-silver mineralisation that supports a low-strip, high-margin open pit scenario. The company is boosting its 2026 drilling program to 9,000 metres to explore extensions along the Barje-Liska corridor.

Rapid Critical Metals has reported exceptional silver assay results from its Webbs Silver Project in NSW, including a standout 4m at 1,230 g/t AgEQ intercept and a significant 300m southern extension of mineralisation. The company is accelerating drilling with a third rig and advancing resource growth plans.

Domino’s Pizza Enterprises reported a $134.2 million statutory loss for FY26 due to significant non-cash impairments, while underlying profit rose 4%. The company is closing up to 60 stores and focusing on franchisee profitability and cost reductions.

DroneShield Limited reported record revenue of $125.8 million for the half-year ended June 2026, driven by recurring income and geographic diversification, while posting a $32.2 million statutory loss due to margin pressure and strategic investments.

L1 Global Long Short Fund (ASX:GLS) reported a striking $121.3 million net profit for FY26 following its strategic reset, declaring a fully franked 2.00 cent final dividend and targeting 8.00 cents per share for FY27.

The Koala Company posted a $24.6 million profit for FY26 on $332.3 million revenue, surpassing IPO forecasts with strong international growth and margin gains.

Mastermyne Group Limited (ASX:MYE) delivered a robust FY26 with revenue up 13% to $237.7 million and underlying profit before tax surging 148% to $15.7 million, supported by contract wins and a record order book.

Radiopharm Theranostics has dosed the first patient in the second cohort of its Phase 1/2a trial for RV-01, a radiopharmaceutical targeting B7-H3 expressing solid tumors, marking a key dose escalation milestone.

BCAL Diagnostics has increased its shareholding in Genetic Signatures to nearly a fifth, aiming to leverage infectious disease technology to complement its cancer detection portfolio.

Biome Australia has delivered a standout FY26 with sales up 30% to $23.9 million and net profit after tax soaring to $3.6 million, bolstered by a non-cash deferred tax asset. The company strengthened its balance sheet while expanding manufacturing and international distribution.

Paladin Energy Ltd (ASX:PDN) reversed prior losses with a net profit of US$5.3 million in FY2026, driven by a strong ramp-up of uranium production at Namibia's Langer Heinrich Mine and regulatory progress at its Canadian Patterson Lake South Project.